Co-Authors
This is a "connection" page, showing publications co-authored by Adrian Laxton and Christopher Whitlow.
Connection Strength
0.667
-
Williams MM, Sohrabi AK, Kittel CA, White JJ, Cramer CK, Lanier CM, Ruiz J, Xing F, Li W, Whitlow CT, Tatter SB, Chan MD, Laxton AW. Delayed Imaging Changes 18 Months or Longer After Stereotactic Radiosurgery for Brain Metastases: Necrosis or Progression. World Neurosurg. 2024 Jan; 181:e453-e458.
Score: 0.230
-
Choi AR, D'Agostino RB, Farris MK, Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Ruiz J, Lycan TW, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Li W, Su J, Whitlow C, Xing F, Chan MD. Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Front Endocrinol (Lausanne). 2024; 15:1364021.
Score: 0.061
-
Ressler HW, Cramer CK, Isom S, McCormack M, Ruiz J, Xing F, Li W, Whitlow CT, White JJ, Laxton AW, Tatter SB, Chan MD. Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomes. Clin Neurol Neurosurg. 2024 Mar; 238:108191.
Score: 0.059
-
Pearce JB, Hsu FC, Lanier CM, Cramer CK, Ruiz J, Lo HW, Xing F, Smith M, Li W, Whitlow C, White JJ, Tatter SB, Laxton AW, Chan MD. Five-year survivors from brain metastases treated with stereotactic radiosurgery: Biology, improving treatments, or just plain luck? Neurooncol Pract. 2023 Apr; 10(2):195-202.
Score: 0.054
-
Su J, Song Q, Qasem S, O'Neill S, Lee J, Furdui CM, Pasche B, Metheny-Barlow L, Masters AH, Lo HW, Xing F, Watabe K, Miller LD, Tatter SB, Laxton AW, Whitlow CT, Chan MD, Soike MH, Ruiz J. Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy. Front Oncol. 2020; 10:615472.
Score: 0.048
-
Wicks RT, Witcher MR, Couture DE, Laxton AW, Popli G, Whitlow CT, Fetterhoff D, Dakos AS, Roeder BM, Deadwyler SA, Hampson RE. Hippocampal CA1 and CA3 neural recording in the human brain: validation of depth electrode placement through high-resolution imaging and electrophysiology. Neurosurg Focus. 2020 07; 49(1):E5.
Score: 0.046
-
Helis CA, Hughes RT, Glenn CW, Lanier CM, Masters AH, Dohm A, Ahmed T, Ruiz J, Triozzi P, Gondal H, Cramer CK, Tatter SB, Laxton AW, Xing F, Lo HW, Su J, Watabe K, Wang G, Whitlow CT, Chan MD. Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):295-303.
Score: 0.046
-
LeCompte MC, Hughes RT, Farris M, Masters A, Soike MH, Lanier C, Glenn C, Cramer CK, Watabe K, Su J, Ruiz J, Whitlow CT, Wang G, Laxton AW, Tatter SB, Chan MD. Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery. J Neurooncol. 2020 Jan; 146(2):285-292.
Score: 0.044
-
Lanier CM, Hughes R, Ahmed T, LeCompte M, Masters AH, Petty WJ, Ruiz J, Triozzi P, Su J, O'Neill S, Watabe K, Cramer CK, Laxton AW, Tatter SB, Wang G, Whitlow C, Chan MD. Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. Neurooncol Pract. 2019 Sep; 6(5):402-409.
Score: 0.041
-
Hampson RE, Song D, Robinson BS, Fetterhoff D, Dakos AS, Roeder BM, She X, Wicks RT, Witcher MR, Couture DE, Laxton AW, Munger-Clary H, Popli G, Sollman MJ, Whitlow CT, Marmarelis VZ, Berger TW, Deadwyler SA. Developing a hippocampal neural prosthetic to facilitate human memory encoding and recall. J Neural Eng. 2018 06; 15(3):036014.
Score: 0.039